![John Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 392 524 $ al 31/07/2026
John R.
Moore is General Counsel at Edgewise Therapeutics, Inc. since 2020.
Formerly, Mr. Moore was Independent Director at Nivalis Therapeutics, Inc. from 2012 to 2017, Secretary & General Counsel at Peloton Therapeutics, Inc. from 2018 to 2019, Counsel at Instil Bio, Inc. in 2020, Secretary, Vice President & General Counsel at Array BioPharma, Inc. from 2002 to 2017, Senior Vice President-Human Resources at Calpine LLC, Attorney at Wilson Sonsini Goodrich & Rosati PC from 1999 to 2002, Attorney at Arnold White & Durkee Corp.
from 1996 to 1999, and Attorney at Kenyon & Kenyon LLP from 1992 to 1996.
Education includes an undergraduate degree from The University of North Carolina at Chapel Hill in 1986, a graduate degree from the University of Illinois At Urbana–Champaign in 1989, and a doctorate from UNC School of Law in 1992.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/08/2025 | 10.214 ( 0,01 % ) | 392 524 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Consejero General | 01/09/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| INSTIL BIO, INC. | Corporate Officer/Principal | 01/12/2020 |
| PELOTON THERAPEUTICS, INC. | Consejero General | 01/09/2019 |
| ARRAY TECHNOLOGIES, INC. | Consejero General | 01/09/2017 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Director/Miembro de la Junta | 01/07/2017 |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2002 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Calpine Corp.
 Calpine Corp. Electric UtilitiesUtilities Generates and supplies electricity from natural gas & geothermal resources | Utilities |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Arnold White & Durkee Corp.
 Arnold White & Durkee Corp. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenyon & Kenyon LLP
 Kenyon & Kenyon LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
UNC School of Law
 UNC School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
